First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial
Lin Wang, Xuezhi Hao, Yanrong Hao, Yanping Hu et autres
cn, hk (code pays fourni par la source)